Install
Vision Monday is the ophthalmic industry's leading source of news and news analysis. Established in 1987, VisionMonday provides valuable insights into how successful retailers and practitioners build their businesses and stay profitable.
- 62articles · 30d
- 2+ day agolatest article
- Aug 18, 2026earliest in window
- 94%with images
- 159avg words
- Health & Wellness 30
- Economy, Business & Finance 26
- Finance & Business 25
- Medical 23
- News 13
- Health 12
- Arts, Culture, Entertainment & Media 9
- Business & Industrial 8
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Johnson & Johnson Tags Jacqueline Henderson as Company Group Chair, Vision
2+ day, 20+ hour ago (348+ words) JACKSONVILLE, Fla.—Global healthcare company Johnson & Johnson (NYSE: JNJ) has announced the appointment of Jacqueline Henderson to the role of company group chair, vision, effective immediately. Henderson has served as interim company group chair for the past three months, the…...
Sightview Introduces New Platform for Ophthalmologists
5+ day, 12+ hour ago (424+ words) VisionMonday.com...
SpyGlass Pharma Opens New 33,000-Square-Foot Headquarters in Irvine
1+ week, 6+ day ago (438+ words) IRVINE, Calif.—SpyGlass Pharma (Nasdaq: SGP), a late-stage biopharmaceutical company focused on intraocular lens and drug delivery solutions for chronic eye conditions such as glaucoma, announced it recently celebrated the grand opening of its new 33,000-square-foot headquarters in Irvine, Calif.,…...
United Opticians Association Installs 2027 Board, Moves to Expand National Certification Drive
2+ week, 4+ day ago (496+ words) LEXINGTON, Ky.—The United Opticians Association (UOA) has announced its 2027 board of directors, which began its work this month after meeting in July to form key committees. The new board will help guide UOA's strategic direction, oversee the organization's growth,…...
BioTissue Adds Ophthalmic Veteran Chris Calcaterra to Its Board
2+ week, 4+ day ago (351+ words) MIAMI—BioTissue, a leader in regenerative healing across the ocular surface disease continuum, has announced the appointment of ophthalmic industry veteran Chris Calcaterra to its board of directors, effective immediately. Calcaterra joins the board as an independent director, bringing decades…...
Eyecare and Preventative Healthcare
2+ week, 5+ day ago (64+ words) VisionMonday.com This article was created using several editorial tools, that may include using AI as part of the process. Human editors reviewed this content before publication. MORE ON: SCENE + HEARD Cast Your Votes for Jobson's 2026 EyeVote Readers' Choice Awards,…...
AI Interest Is Growing in Healthcare and Optometry, But Privacy and Integration Concerns Persist
2+ week, 6+ day ago (520+ words) NEWARK, N.J.—Healthcare practices, including optometry offices, are increasingly open to artificial intelligence (AI) as a way to improve operations, but new survey data suggest adoption remains in an early stage as concerns about privacy, quality and workflow integration continue to…...
WO Voices Presents Public Health Focused Episode Featuring Dr. Araba Otoo
3+ week, 3+ day ago (107+ words) VisionMonday.com Top Line: Women In Optometry presents a new episode of its WO Voices podcast featuring Mary âArabaâ Otoo, OD, MPH, FAAO, chair of the American Public Health Association Vision Care Section.Close Up: In this episode, Dr…...
Ora Taps John Trein, MD, to Lead Posterior Segment Strategy and Development
3+ week, 3+ day ago (409+ words) BOSTON—Ora, a global ophthalmic contract research organization (CRO), has appointed João (John) Trein, MD, MPH, as therapeutic lead, posterior, further strengthening the company's leadership in retinal disease and posterior segment drug development, according to an announcement from Ora. A…...
FDA Broadens ‘Indications for Use’ for Sight Sciences’ TearCare System
3+ week, 3+ day ago (407+ words) MENLO PARK, Calif.—Eyecare tech company Sight Sciences, Inc. (Nasdaq: SGHT) announced that, effective August 18, 2026, the U.S. Food and Drug Administration (FDA) updated the indications for use for its TearCare System, allowing it to be used for improving meibomian gland…...